Home LiteratureArticle Details
PMID: 11232196 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Mechanisms of cholestasis.

Clinics in liver disease ·Vol. 4 ·No. 2 ·2000-05-00 ·Pages 357-85

Kullak-Ublick GA, Meier PJ

Abstract

From the multiple mechanisms of cholestasis presented in this article, a unifying hypothesis may be deduced by parsimony. The disturbance of the flow of bile must inevitably lead to the intracellular retention of biliary constituents. Alternatively, the lack of specific components of bile unmasks the toxic potential of other components, as in the case of experimental mdr2 deficiency. In the sequence of events that leads to liver injury, the cytotoxic action of bile salts is pivotal to all forms of cholestasis. The inhibition of the bsep by drugs, sex steroids, or monohydroxy bile salts is an example of direct toxicity to the key mediator in canalicular bile salt excretion. In other syndromes, the dysfunction of distinct hepatocellular transport systems is the primary pathogenetic defect leading to cholestasis. Such dysfunctions include the genetic defects in PFIC and the direct inhibition of gene transcription by cytokines. Perturbations in the short-term regulation of transport protein function are exemplified by the cholestasis of endotoxinemia. The effect of bile salts on signal transduction, gene transcription, and transport processes in hepatocytes and cholangiocytes has become the focus of intense research in recent years. The central role of bile salts in the pathogenesis of cholestasis has, ironically, become all the more evident from the improvement of many cholestatic syndromes with oral bile salt therapy.

MeSH Terms
Apoptosis/physiology Bile Acids and Salts/metabolism,physiology,therapeutic use Cholestasis/etiology,physiopathology,therapy Cholestasis, Extrahepatic/physiopathology Estradiol/adverse effects Humans Hydroxyl Radical/metabolism Parenteral Nutrition/adverse effects Syndrome
Chemicals
Bile Acids and Salts Hydroxyl Radical Estradiol
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Kullak-Ublick G A
Division of Clinical Pharmacology and Toxicology, Department of Medicine, University Hospital, Zurich, Switzerland. kullak@kpt.unizh.ch
Meier P J
Article Info
Journal
Clinics in liver disease
Abbr.
Clin Liver Dis
ISSN
1089-3261
Published
2000-05-00
Pages
357-85
Language
English
Region
United States
NLM ID
9710002
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com